FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Loxapine Capsules
Status: Currently in Shortage
»Date first posted: 11/25/2019
»Therapeutic Categories: Psychiatry

Expand all

Lannett Company, Inc. (Revised 05/20/2020)

Company Contact Information:
215-333-9000 ext. 4

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg, 100 count bottle (NDC 0527-1394-01) Unavailable. Additional lots are scheduled for release in the June timeframe. Product will be made available as it is released (allocating inventory). Manufacturing capacity constraint Other
5 mg, 1000 count bottle (NDC 0527-1394-10) Unavailable

Link to Discontinuance

Discontinuation of the manufacture of the drug
10 mg, 100 count bottle (NDC 0527-1395-01) Allocating Inventory. Additional lots are scheduled for release in the June timeframe. Product will be made available as it is released (allocating inventory). Manufacturing capacity constraint Other
10 mg, 1000 count bottle (NDC 0527-1395-10) Unavailable

Link to Discontinuance

Discontinuation of the manufacture of the drug
25 mg, 100 count bottle (NDC 0527-1396-01) Unavailable. Additional lots are scheduled for release in the June timeframe. Product will be made available as it is released (allocating inventory). Manufacturing capacity constraint Other
25 mg, 1000 count bottle (NDC 0527-1396-10) Unavailable

Link to Discontinuance

Discontinuation of the manufacture of the drug
50 mg, 100 count bottle (NDC 0527-1397-01) Unavailable. Next release date not available at this time. Manufacturing capacity constraint Other
50 mg, 1000 count bottle (NDC 0527-1397-10) Unavailable

Link to Discontinuance

Discontinuation of the manufacture of the drug

Mylan (Reverified 04/03/2020)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg, 100 count bottle (NDC 0378-7005-01) Unavailable. Re-supply TBD. Other
10 mg, 100 count bottle (NDC 0378-7010-01) Unavailable. Re-supply TBD. Other
25 mg, 100 count bottle (NDC 0378-7025-01) Unavailable. Re-supply TBD. Other
50 mg, 100 count bottle (NDC 0378-7050-01) Unavailable. Re-supply TBD. Other

Teva Pharmaceuticals (Revised 06/18/2020)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg, 100 count bottle (NDC 0591-0369-01) On backorder, expected recovery July 2020 Cannot support additional business currently.
10 mg, 100 count bottle (NDC 0591-0370-01) On backorder, expected recovery July 2020 Cannot support additional business currently. Other
25 mg, 100 count bottle (NDC 0591-0371-01) Product is available Cannot support additional business currently.
50 mg, 100 count bottle (NDC 0591-0372-01) On backorder. Recovery expected July 2020 Cannot support additional business currently.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English